All Work

Chris Lange

Fluidigm Tumbles on Weak Earnings

Shares tumbled after Fluidigm reported disappointing second-quarter financial results and lowered guidance.

Chris Lange · 11 years ago

DepoMed Fires Back at Horizon Pharma

Shots were fired again on the Horizon Pharma and DepoMed merger front. However it was DepoMed this time pushing back.

Chris Lange · 11 years ago

Can Aquinox Sustain Its Massive Rally?

Aquinox Pharmaceuticals made waves in the market Friday morning, with shares up over 200%, after it announced results from a Phase 2 trial.

Chris Lange · 11 years ago

Why Zynga Couldn’t Clear Its Earnings

courtesy of ZyngaZynga, Inc. (NASDAQ: ZNGA) reported its second-quarter financial results after the markets closed Thursday. The video game developer had a net loss of $0.01 per share on $200 million in revenue compared…

Chris Lange · 11 years ago

5 Big FDA Decisions Expected in August

24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of August and added some color.

Chris Lange · 11 years ago

Hospitality Earnings in Review

ThinkstockA few of the key hospitality stocks recently reported their earnings and 24/7 Wall St. is taking a quick review of what has happened in the past week. The three companies we included in…

Chris Lange · 11 years ago